These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4629764)

  • 1. [Effect of chlorfibrinic acid on the triglyceride and glycogen contents of human liver as well as on blood-level forming metabolites].
    Hanefeld M; Jaross W; Trübsbach A; Leonhardt W
    Z Gesamte Inn Med; 1972 Aug; 27(15):655-8. PubMed ID: 4629764
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does magnesium-orotate improve the effect of lipid lowering drugs?].
    Irsigler K; Flegel U; Kühn P; Schubert H; Iván E; Biro L; Székely L
    Int J Clin Pharmacol; 1973 Aug; 8(1):85-95. PubMed ID: 4727450
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver morphology and liver function in delirium tremens].
    Irsigler K; Kryspin-Exner K; Mildschuh W; Pointner H; Schmidt P
    Dtsch Med Wochenschr; 1971 Jan; 96(1):9-13. PubMed ID: 5540002
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effect of Ciba 13437-Su in 40 patients with familial essential hyperlipemia].
    Schönbeck M; Forster G; Hirzel H; Jakab T; Rosenmund H
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1761-8. PubMed ID: 5451984
    [No Abstract]   [Full Text] [Related]  

  • 5. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
    Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
    Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)].
    von Löwis P; Klemens UH
    Dtsch Med Wochenschr; 1973 Dec; 98(49):2328-33. PubMed ID: 4357927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatotoxic effects of 2-methyl-2-(p-(1,2,3,4-tetrahydro-1-naphthyl)-phenoxy)propionic acid (Ciba 13,437-Su)].
    Kattermann R; Arnold R; Creutzfeldt W
    Arzneimittelforschung; 1972 Mar; 22(3):616-9. PubMed ID: 4624899
    [No Abstract]   [Full Text] [Related]  

  • 8. [Liver findings in primary hyperlipoproteinemia (HLP)].
    Renger F; Hanefeld M; Jaross W; Stötzner H; Kemmer C; Leonhardt W; Trübsbach A; Schentke KU
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(4):199-203. PubMed ID: 4365203
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of fatty liver with essential phospholipids].
    Arendt R; Nowotny P; Teichmann W
    Z Gesamte Inn Med; 1970 Jul; 25(13):587-9. PubMed ID: 5523267
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
    Hanefeld M; Schulze J; Fritz T; Kemmer C
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
    [No Abstract]   [Full Text] [Related]  

  • 13. Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice.
    Chen J; Ma M; Lu Y; Wang L; Wu C; Duan H
    Planta Med; 2009 Apr; 75(5):472-7. PubMed ID: 19235684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between plasminogen activator inhibitor-1 and hepatic enzyme concentrations in hyperlipidemic patients.
    Bruckert E; Ankri A; Giral P; Turpin G
    Thromb Haemost; 1994 Sep; 72(3):434-7. PubMed ID: 7855796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
    Mertz DP; Sulzberger I; Klöpfer M
    Munch Med Wochenschr; 1970 Feb; 112(6):241-7. PubMed ID: 5537894
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the behavior of fat metabolism during treatment of fatty liver with Nucleoton].
    Kark B
    Med Welt; 1971 Mar; 10():400-1. PubMed ID: 5549140
    [No Abstract]   [Full Text] [Related]  

  • 17. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease.
    Hong X; Tang H; Wu L; Li L
    J Pharm Pharmacol; 2006 Oct; 58(10):1391-8. PubMed ID: 17034663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in blood chemistry and liver histopathology of rabbits during experimental tetanus toxicity.
    Sofola OA; Elesha SO
    Afr J Med Med Sci; 1985; 14(3-4):185-91. PubMed ID: 3004179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
    Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on treating hyperlipidemic fatty liver with Taizhi'an capsule].
    Sun M; Shan JZ; Zhang GP; Ying HZ
    Zhongguo Zhong Yao Za Zhi; 2007 Apr; 32(7):616-9. PubMed ID: 17583205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.